🔬 Current Disease Focus:
Task Progress: 0%
👥 Active Problem Solvers
0
🌍 Experts collaborating globally
⚡ Current Task Assignment
🧬 Genetic Analysis
🔄 Matching experts to specific tasks
📊 Resource Allocation by Research Phase:
📚 Data Analysis
🧪 Experimental Design
🔬 Clinical Trials
💊 Treatment Development
A randomized, double-blind, controlled, multicenter phase III study of TQB2...
Status
Unknown
Location
The First Affiliated Hospital of Bengbu Medical College
Start Date
2020-01
Trial ID
NCT04234607
Treatments Being Tested
Objective to compare the efficacy and safety of TQB2450 injection combined ...
Status
Recruiting
Location
The Central People's Hospital of Huizhou
Start Date
2023-04-12
Trial ID
NCT06141226
Treatments Being Tested
This study is a randomized, double-blind, placebo-controlled phase III clin...
Status
Not Yet Recruiting
Location
Anhui Provincial Hospital
Start Date
2024-09
Trial ID
NCT06469879
Treatments Being Tested
A clinical study to evaluate the efficacy and safety of TQB2450 injection c...
Status
Unknown
Location
China-Japan Friendship Hospital
Start Date
2021-08-06
Trial ID
NCT04964479
Treatments Being Tested
This study is a randomized, double-blind, double-dummy,placebo parallel con...
Status
Unknown
Location
Anhui Chest Hospital
Start Date
2020-05-27
Trial ID
NCT04325763
Treatments Being Tested
TQB2450 is a humanized monoclonal antibody targeting programmed death ligan...
Status
Unknown
Location
Gansu Province Tumor Hospital
Start Date
2019-06-11
Trial ID
NCT03910127
This is Phase 3, randomized, double-blind, parallel controlled study design...
Status
Unknown
Location
Chinese Academy of Medical Sciences Cancer Hospital
Start Date
2023-02
Trial ID
NCT05718167
Treatments Being Tested